These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2719845)

  • 1. Prevalence and prediction of psychotropic drug use in California developmental centers.
    Stone RK; Alvarez WF; Ellman G; Hom AC; White JF
    Am J Ment Retard; 1989 May; 93(6):627-32. PubMed ID: 2719845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment strategies for self-injurious behavior in a large service-delivery network.
    Altmeyer BK; Locke BJ; Griffin JC; Ricketts RW; Williams DE; Mason M; Stark MT
    Am J Ment Defic; 1987 Jan; 91(4):333-40. PubMed ID: 3812603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A national study of prescribed drugs in institutions and community residential facilities for mentally retarded people.
    Hill BK; Balow EA; Bruininks RH
    Psychopharmacol Bull; 1985; 21(2):279-84. PubMed ID: 4001292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychotropic medication of mentally retarded residents in community long-term care facilities.
    Buck JA; Sprague RL
    Am J Ment Retard; 1989 May; 93(6):618-23. PubMed ID: 2566316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychopharmacology of self-injurious behavior in the mentally retarded.
    Farber JM
    J Am Acad Child Adolesc Psychiatry; 1987 May; 26(3):296-302. PubMed ID: 2885304
    [No Abstract]   [Full Text] [Related]  

  • 6. A survey of psychotropic medication in mental retardation facilities.
    Tu JB
    J Clin Psychiatry; 1979 Mar; 40(3):125-8. PubMed ID: 33967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring and evaluating psychotropic drug use for persons with mental retardation: a follow-up report.
    Briggs R
    Am J Ment Retard; 1989 May; 93(6):633-9. PubMed ID: 2719846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic management of aggressivity and self-mutilation in the mentally retarded.
    Lapierre YD; Reesal R
    Psychiatr Clin North Am; 1986 Dec; 9(4):745-54. PubMed ID: 3543893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Buspirone therapy for maladaptive behavior and anxiety in developmentally disabled persons.
    Ratey JJ; Sovner R; Mikkelsen E; Chmielinski HE
    J Clin Psychiatry; 1989 Oct; 50(10):382-4. PubMed ID: 2793836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maladaptive behaviors associated with neuroleptic drug maintenance.
    Chadsey-Rusch J; Sprague RL
    Am J Ment Retard; 1989 May; 93(6):607-17. PubMed ID: 2566315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pervasive developmental disorder, behavior problems, and psychotropic drug use in children and adolescents with mental retardation.
    de Bildt A; Mulder EJ; Scheers T; Minderaa RB; Tobi H
    Pediatrics; 2006 Dec; 118(6):e1860-6. PubMed ID: 17142506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychoactive drug use in public and community residential facilities for mentally retarded persons.
    Intagliata J; Rinck C
    Psychopharmacol Bull; 1985; 21(2):268-78. PubMed ID: 4001291
    [No Abstract]   [Full Text] [Related]  

  • 13. [Psychotropic medicines to patients with mental retardation].
    Bygdnes AM; Kristiansen A
    Tidsskr Nor Laegeforen; 2007 Apr; 127(8):1028-30. PubMed ID: 17457386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishing socially validated drug research in community settings.
    Agran M; Martin JE
    Psychopharmacol Bull; 1985; 21(2):285-90. PubMed ID: 3889971
    [No Abstract]   [Full Text] [Related]  

  • 15. Beta adrenergic blocking medications for aggressive or self-injurious mentally retarded persons.
    Ruedrich SL; Grush L; Wilson J
    Am J Ment Retard; 1990 Jul; 95(1):110-9. PubMed ID: 1974768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment with psychotropic drugs in various facilities for mentally handicapped patients].
    Meins W; Auwetter J; Krausz M; Turnier Y
    Nervenarzt; 1993 Jul; 64(7):451-5. PubMed ID: 8103571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychotropic drug use in intellectually disabled group-home residents with behavioural problems.
    Stolker JJ; Koedoot PJ; Heerdink ER; Leufkens HG; Nolen WA
    Pharmacopsychiatry; 2002 Jan; 35(1):19-23. PubMed ID: 11819154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacotherapy and mental retardation/developmental disability: a bibliography. (Special emphasis on non-institutionalized populations).
    Reatig N
    Psychopharmacol Bull; 1985; 21(2):329-33. PubMed ID: 3889973
    [No Abstract]   [Full Text] [Related]  

  • 19. [How should mentally handicapped adults with depressive disorders be treated psychopharmacologically?].
    Meins W
    Nervenarzt; 1996 Mar; 67(3):216-8. PubMed ID: 8901279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of interdisciplinary team review on psychotropic drug use with persons who have mental retardation.
    Findholt NE; Emmett CG
    Ment Retard; 1990 Feb; 28(1):41-6. PubMed ID: 2308511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.